ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,882.57
0.74%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Proteostasis Therapeutics Inc (PTI)

  7. Proteostasis Therapeutics Inc (PTI) Noticias

PTI

Proteostasis Therapeutics (PTI)

Proteostasis Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PTI
FechaHoraFuenteTítuloSímboloCompañía
29/06/202306:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
16/06/202315:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
13/06/202309:32Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTIProteostasis Therapeutics Inc
12/06/202316:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PTIProteostasis Therapeutics Inc
01/06/202315:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIProteostasis Therapeutics Inc
11/05/202316:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202316:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202316:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202316:12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PTIProteostasis Therapeutics Inc
21/04/202316:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIProteostasis Therapeutics Inc
31/03/202315:11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PTIProteostasis Therapeutics Inc
14/02/202315:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTIProteostasis Therapeutics Inc
14/02/202315:16Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PTIProteostasis Therapeutics Inc
10/02/202315:55Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PTIProteostasis Therapeutics Inc
10/02/202308:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTIProteostasis Therapeutics Inc
23/12/202205:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTIProteostasis Therapeutics Inc
16/12/202213:58Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PTIProteostasis Therapeutics Inc
16/12/202209:38Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:PTIProteostasis Therapeutics Inc
06/12/202215:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PTIProteostasis Therapeutics Inc
04/11/202215:53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PTIProteostasis Therapeutics Inc
20/12/202115:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:PTIProteostasis Therapeutics Inc
17/08/202116:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTIProteostasis Therapeutics Inc
06/01/202116:29Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PTIProteostasis Therapeutics Inc
22/12/202009:47PR Newswire (US)Proteostasis Therapeutics, Inc. Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Revers...NASDAQ:PTIProteostasis Therapeutics Inc
15/12/202006:00GlobeNewswire Inc.Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with ProteostasisNASDAQ:PTIProteostasis Therapeutics Inc
16/11/202015:15PR Newswire (US)Proteostasis Therapeutics Reports Third Quarter 2020 Financial ResultsNASDAQ:PTIProteostasis Therapeutics Inc
23/09/202015:51Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PTIProteostasis Therapeutics Inc
25/08/202014:41Business WireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Proteostasis Therapeutics, Inc.NASDAQ:PTIProteostasis Therapeutics Inc
24/08/202013:14Dow Jones NewsBiotech Startup Yumanity Sets Reverse Merger With ProteostasisNASDAQ:PTIProteostasis Therapeutics Inc
24/08/202006:00PR Newswire (US)Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger AgreementNASDAQ:PTIProteostasis Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PTI

Su Consulta Reciente

SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MRK
Merck
NYSE
AXP
American Express
AMEX
XLE
Energy Select Sector SPDR
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados